Kyle Moran, Chief Financial Officer at Wave Life Sciences Ltd. (WVE), sold 9,204 shares at $2.31 ($21K) on 2022-02-16, disclosed to the SEC on 2022-02-18.
Open-market sale of $21k WVE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| WVE | SELL | 2024-09-27 | $154K | — | Filing → |
| WVE | SELL | 2024-04-05 | $193K | — | Filing → |
| WVE | SELL | 2023-08-23 | $352K | — | Filing → |